Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases.
Saibeni
S
S
Gastroenterology and Gastrointestinal Endoscopy Service and Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, Department of Internal Medicine and Dermatology, IRCCS Maggiore Hospital, University of Milan, Via Pace 9, 20122 Milan, Italy.
Bottasso
B
B
Spina
L
L
Bajetta
M
M
Danese
S
S
Gasbarrini
A
A
de Franchis
R
R
Vecchi
M
M
D000328:Adult; D025901:Carboxypeptidase B2 / Q000097:blood*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood*; D008297:Male
D025901:Carboxypeptidase B2